Trial Profile
Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 03 Jul 2008 New trial record.
- 03 Jun 2008 Celgene Corporation as company and lead trial centre added as reported by ClinicalTrials.gov.